Pharma News

The FDA has approved treatment for adults with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.

GLP-1RA Alzheimer’s hopes dashed after Novo Nordisk’s semaglutide miss

Eli Lilly flies the pharma flag in tech-heavy $1tn market cap club

Angelini Pharma has been taken to task under the UK pharma industry's code of practice for criticising licensing decisions made by the EU medicines regulator at one of its promotional meetings. ...

Actio Biosciences to Present New Preclinical Data for ABS-1230, a KCNT1 Inhibitor for the Treatment of Epilepsy

Navigating the FDA’s import operations for pharmaceuticals and biologics

Merck KGaA eyes new Parkinson’s disease assets with $3bn Valo partnership

FDA Approves Perioperative Enfortumab Vedotin Plus Pembrolizumab for Cisplatin-Ineligible MIBC

ALS oral therapy slows disease progression in preclinical testing

Alvotech and Advanz announce EC approval for Gobivaz biosimilar

Blood-Based Screening Test May Increase Preclinical Lung Cancer Detection

CorriXR Therapeutics Announces Publication of Preclinical Data Demonstrating Potential of CRISPR-Directed Gene Editing to Overcome Drug Resistance in Solid Tumors